Application status and research progress in perioperative chemoradiotherapy for T 3 rectal cancer

VernacularTitle:T 3期直肠癌围手术期放化疗的应用现状及研究进展
Author: Xin JI ¹ ; Chunying LI ; Jinwei LUAN ; Yang ZHOU ; Jiaqi LI ; Xianglan LI
Author Information

1. 哈尔滨医科大学附属肿瘤医院腹部放疗科，哈尔滨　150000
Keywords: Rectal neoplasms; Chemoradiotherapy; T 3 subclassifications
From: Chinese Journal of Radiation Oncology 2023;32(11):1010-1014
CountryChina
Language:Chinese
Abstract: T 3 rectal cancer patients are a heterogeneous group of populations. T 3 stage patients with good prognosis are similar to their T 2 stage counterparts, and T 3 stage patients with poor prognosis are similar to T 4 stage counterparts. Although small sample clinical trials, meta-analyses and retrospective analyses have been conducted, clinical guidelines are not completely consistent with the definition of risk factors and treatment recommendations for this group of populations. At present, the treatment strategy for T 3 rectal cancer is still controversial, especially the application of perioperative radiotherapy. In this article, current application status and research progress in perioperative chemoradiotherapy for T 3 rectal cancer were reviewed.